NVST logo

Envista Holdings Corporation Stock Price

NYSE:NVST Community·US$3.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

NVST Share Price Performance

US$22.00
2.66 (13.75%)
US$27.00
Fair Value
US$22.00
2.66 (13.75%)
12.0% undervalued intrinsic discount
US$25.00
Fair Value
Price US$22.00
AnalystHighTarget US$25.00
AnalystLowTarget US$17.00
AnalystConsensusTarget US$22.15

NVST Community Narratives

AnalystHighTarget·
Fair Value US$27 18.5% undervalued intrinsic discount

Aging Populations And Digital Dentistry Will Drive Global Dental Growth

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystLowTarget·
Fair Value US$17 29.4% overvalued intrinsic discount

Digital Dentistry And Regulatory Pressures Will Crush Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$22.15 0.7% undervalued intrinsic discount

NVST: Profit Margin Expansion And Core Momentum Will Offset Mixed Near-Term Performance

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
US$17
29.4% overvalued intrinsic discount
Revenue
2.92% p.a.
Profit Margin
12.49%
Future PE
9.31x
Price in 2028
US$21.62

Trending Discussion

Updated Narratives

NVST logo

NVST: Margin Expansion And Share Repurchases Will Drive Stronger Future Earnings Power

Fair Value: US$27 18.5% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NVST logo

NVST: Tighter EPS Guidance And Profitability Improvements Will Shape 2025 Outlook

Fair Value: US$22.15 0.7% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NVST logo

Digital Dentistry And Regulatory Pressures Will Crush Margins

Fair Value: US$17 29.4% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet and good value.

1 Risk
4 Rewards

Envista Holdings Corporation Key Details

US$2.6b

Revenue

US$1.2b

Cost of Revenue

US$1.5b

Gross Profit

US$1.5b

Other Expenses

US$15.3m

Earnings

Last Reported Earnings
Sep 26, 2025
Next Reporting Earnings
n/a
0.093
56.05%
0.58%
46.8%
View Full Analysis

About NVST

Founded
2018
Employees
12300
CEO
Paul Keel
WebsiteView website
envistaco.com

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Recent NVST News & Updates

Recent updates

No updates